{"id":"fipv-0-1-ml-id","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (pain, erythema, induration)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"fIPV (fractional inactivated polio vaccine) contains chemically inactivated poliovirus antigens that trigger humoral and cellular immune responses without causing disease. The vaccine is administered intradermally in a reduced dose (0.1 mL) compared to standard intramuscular IPV, providing immunogenicity while conserving vaccine supply. This formulation is used in outbreak response and resource-limited settings to extend vaccine availability.","oneSentence":"fIPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:46:26.415Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Poliomyelitis prevention in outbreak response and immunization campaigns"},{"name":"Polio vaccination in resource-limited settings using fractional dosing"}]},"trialDetails":[{"nctId":"NCT04063150","phase":"PHASE4","title":"Immunogenicity of Intramuscular and Intradermal IPV","status":"TERMINATED","sponsor":"Centers for Disease Control and Prevention","startDate":"2019-10-06","conditions":"Poliomyelitis","enrollment":958}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"fIPV (0.1 mL) ID","genericName":"fIPV (0.1 mL) ID","companyName":"Centers for Disease Control and Prevention","companyId":"centers-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"fIPV (0.1 mL) ID is a vaccine intervention being studied for Poliomyelitis. The study, \"Immunogenicity of Intramuscular and Intradermal IPV,\" is being conducted by the Centers for Disease Control and Prevention to evaluate the immunogenicity of intradermal inactivated poliovirus vaccine.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}